hyperglycaemia

Related by string. * * *

Related by context. All words. (Click for frequent words.) 73 elevated triglyceride levels 73 metabolic acidosis 72 hyperglycemia 71 Hypoglycaemia 71 glycated hemoglobin levels 70 glycemia 70 hyperinsulinemia 70 atherogenic dyslipidemia 70 glycaemia 70 microvascular complications 70 decompensated heart failure 70 glycosylated hemoglobin HbA1c 70 T2DM 70 extrapyramidal symptoms 69 macrovascular disease 69 Erythropoietic therapies may 69 macroalbuminuria 69 hypoglycemic episodes 68 cytopenias 68 hypoxemia 68 artery stenosis 68 autonomic dysfunction 68 subclinical hypothyroidism 68 metabolic disturbances 68 blood glucose concentrations 68 lowering blood glucose 68 β blockers 68 hyperprolactinemia 68 postoperative AF 68 nephrotoxicity 68 hypocalcemia 68 systolic hypertension 68 hypoperfusion 67 abnormal lipids 67 torsade de pointes 67 Severe hypoglycemia 67 elevated blood glucose 67 hyperkalemia 67 PAOD 67 airway hyperresponsiveness 67 myocardial ischemia 67 abdominal adiposity 67 left ventricular dysfunction 67 prolonged QT interval 67 SGPT 67 hyperparathyroidism 67 LV dysfunction 67 hepatic cirrhosis 67 hypercholesterolaemia 67 diabetic kidney 67 cardiovascular morbidity 67 elevated uric acid 67 dysfunction LVSD 67 cardiac dysfunction 67 serum phosphate 67 transaminase levels 67 thyrotoxicosis 67 platelet reactivity 67 vascular inflammation 67 elevated triglycerides 67 metabolic abnormalities 67 Hypotension 67 thromboembolic 67 diabetes mellitus T2DM 67 nocturnal hypoglycaemia 66 elevated fasting glucose 66 hepatorenal syndrome 66 atrophic gastritis 66 fasting glucose levels 66 Insulin resistance 66 microvascular disease 66 hypovitaminosis D 66 diabetes mellitus DM 66 gastro oesophageal reflux 66 cerebral infarction 66 renal insufficiency 66 diabetes dyslipidemia 66 variceal bleeding 66 autoantibody levels 66 thrombocytopenia neutropenia 66 microangiopathy 66 hypophosphatemia 66 primary aldosteronism 66 hypertension diabetes mellitus 66 microalbuminuria 66 Endothelial dysfunction 66 elevated ALT 66 plasma triglycerides 66 EXJADE 66 coagulopathy 66 elevated creatinine 66 severe hypoglycaemia 66 IPAH 66 elevated LDL cholesterol 66 serum uric acid 66 antioxidant supplementation 66 serum urate levels 66 HeFH 66 aortic valve stenosis 66 thrombotic events 66 lipid levels 66 vasodilatation 66 serum triglycerides 66 chronic thromboembolic pulmonary 66 thyrotropin 66 symptomatic VTE 66 hyperlipidaemia 66 lipid abnormalities 66 unstable angina pectoris 66 predisposing factor 66 T1DM 66 hyperalgesia 66 adiponectin levels 65 Impaired glucose tolerance 65 proliferative diabetic retinopathy 65 alanine aminotransferase ALT 65 intermittent claudication 65 vasovagal syncope 65 postoperative atrial fibrillation 65 aminotransferases 65 rhythm disturbances 65 fasting triglycerides 65 macrovascular events 65 CVD mortality 65 dyslipidaemia 65 hemorrhagic complications 65 nonalcoholic steatohepatitis NASH 65 mucosal inflammation 65 impaired cognition 65 elevated serum creatinine 65 Chronic pancreatitis 65 central adiposity 65 insulin resistance 65 antiphospholipid syndrome 65 Aortic stenosis 65 glucose homeostasis 65 variant angina 65 parkinsonian symptoms 65 acidosis 65 postoperative pulmonary 65 plasma lipids 65 cardiac insufficiency 65 CP CPPS 65 serum triglyceride levels 65 severe hypoglycemia 65 bronchial hyperresponsiveness 65 electrolyte abnormalities 65 platelet activation 65 Proteinuria 65 type2 diabetes 65 intracerebral haemorrhage 65 endotoxemia 65 myoclonus 65 carotid atherosclerosis 65 impaired glucose metabolism 65 homocysteine concentrations 65 upper gastrointestinal bleeding 65 hypovolemia 65 familial hypercholesterolemia FH 65 Diabetic neuropathy 65 cardiovascular disease hypertension 65 macrovascular complications 65 atherosclerotic disease 65 ketoacidosis 65 oral antidiabetic medication 65 elevated homocysteine 65 gallstone disease 65 prothrombotic 65 diabetes mellitus 65 ABCB1 65 postoperative mortality 65 renal dysfunction 64 comorbid depression 64 pathophysiological mechanisms 64 abnormal glucose metabolism 64 tachyarrhythmias 64 glitazones 64 Thiazolidinediones 64 alanine aminotransferase 64 aspartate aminotransferase AST 64 hyperphenylalaninemia HPA due 64 cardiac conduction 64 diabetic microvascular complications 64 nonalcoholic steatohepatitis 64 hepatic steatosis 64 vaso occlusive crisis 64 airway hyper responsiveness 64 systemic inflammation 64 inducible nitric oxide synthase 64 cerebrovascular events 64 Diabetic nephropathy 64 serum sodium 64 cortisol secretion 64 serum creatinine levels 64 hemodilution 64 hypercalcemia 64 ADPKD 64 reflux symptoms 64 intracranial hemorrhage ICH 64 serum potassium 64 nondiabetic patients 64 apneic episodes 64 tumor lysis syndrome 64 overt nephropathy 64 receiving VELCADE 64 hypercalcaemia 64 eosinophilia 64 occlusive disease 64 severe exacerbations 64 arterial hypertension 64 secondary hyperparathyroidism 64 transaminases 64 neurocognitive deficits 64 atherosclerotic vascular disease 64 cardiometabolic risk 64 acute decompensation 64 ventricular tachyarrhythmia 64 nonfasting triglycerides 64 neuropsychiatric symptoms 64 Hypoglycemia 64 endocannabinoid signaling 64 triacylglycerol concentrations 64 glucose intolerance 64 mixed hyperlipidemia 64 albuminuria 64 primary hyperparathyroidism 64 serum glucose 64 thrombocytosis 64 dopaminergic therapy 64 transaminase elevations 64 CYP #A# 64 dysrhythmias 64 improves insulin sensitivity 64 QTc intervals 64 HbA 1c levels 64 serum calcium levels 64 serum cholesterol 64 glomerular filtration 64 induce orthostatic hypotension 64 serum PTH 64 endothelial dysfunction 64 HIV HCV coinfected 64 hypercoagulable 64 Venous thromboembolism 64 neurologic complications 64 heterozygous FH 64 subclinical atherosclerosis 64 Vitamin D insufficiency 64 fulminant 64 Sleep disturbances 64 clinically meaningful reductions 64 elevated bilirubin 64 thromboembolic complications 64 HbA1c levels 64 thromboembolism 64 metabolic parameters 64 Pulmonary hypertension 64 probiotic supplementation 64 QTc prolongation 64 pancytopenia 64 endothelial activation 64 hypoglycaemic 64 cerebral vasospasm 64 periprocedural 64 postoperative delirium 64 proinflammatory cytokine 64 hypomagnesemia 63 chronic pancreatitis 63 dysglycemia 63 chronic periodontitis 63 heparin induced thrombocytopenia 63 obesity insulin resistance 63 nonfatal myocardial infarction MI 63 serum cortisol 63 leptin resistance 63 fatty acid oxidation 63 left ventricular diastolic 63 silent ischemia 63 insulin resistance syndrome 63 triglyceride concentrations 63 subclinical inflammation 63 daytime drowsiness 63 familial hypercholesterolemia 63 intravascular hemolysis 63 Myocardial infarction 63 hepatic fibrosis 63 hypertension 63 hyperbilirubinemia 63 cerebral ischemia 63 atherothrombosis 63 dysmotility 63 ischemic complications 63 liver dysfunction 63 corticosteroid therapy 63 colorectal adenoma 63 unknown etiology 63 growth hormone secretion 63 amyloid deposition 63 nephropathy 63 bloodpressure 63 hypoglycemic coma 63 hypercholesterolemia 63 torsades de pointes 63 prostate carcinogenesis 63 haemorrhagic stroke 63 onset diabetes mellitus 63 fibrosis scarring 63 leucopenia 63 lipid concentrations 63 acetabular dysplasia 63 serum leptin 63 valvular disease 63 coronary insufficiency 63 hypercalciuria 63 NNT = 63 autoimmune thyroid 63 postural hypotension 63 G6PD deficiency 63 diastolic hypertension 63 hypocalcaemia 63 nondiabetics 63 nonischemic 63 Hyperlipidemia 63 neuronal dysfunction 63 arterial inflammation 63 postprandial insulin 63 systemic corticosteroid 63 tHcy 63 paraneoplastic 63 Hp2 2 63 psoriatic arthritis PsA 63 dermatologic reactions 63 fluid overload 63 Natalizumab 63 SHPT 63 inflammatory markers 63 hepatic function 63 hypoglycemia 63 cardiac autonomic 63 abnormal glucose tolerance 63 somatic symptoms 63 CMV infection 63 hypoglycaemia 63 Vitamin B# deficiency 63 impaired glucose tolerance 63 myopathy rhabdomyolysis 63 hyperhomocysteinemia 63 artherosclerosis 63 progressive dyspnea 63 CTAP# Capsules 63 hydrops 63 NPH insulin 63 pancreas pancreatitis 63 airflow limitation 63 Angiotensin II 63 MULTAQ 63 perioperatively 63 neurologic dysfunction 63 silent myocardial ischemia 63 metabolic syndrome MetS 63 Hyperglycemia 63 Magnesium deficiency 63 proliferative retinopathy 63 improves glycemic 63 Fluid retention 63 dysmenorrhoea 63 Lp PLA 2 63 postprandial glucose 63 intensive statin therapy 63 leukocyte counts 63 Alzheimer Disease AD 63 post thrombotic syndrome 63 Wernicke Korsakoff syndrome 63 postprandial hyperglycemia 63 cholestasis 63 levodopa therapy 63 riociguat 63 recurrent venous thromboembolism 63 atherothrombotic disease 63 glucocorticoid therapy 63 recurrent VTE 63 lipohypertrophy 63 Impaired Glucose Tolerance 63 depressive symptomatology 63 hemoglobin A1c HbA1c 63 symptomatic intracranial 63 pulmonary vascular 63 pyelonephritis 63 haematologic 63 Non Alcoholic Steatohepatitis 63 hypoglycemic events 63 acute myocardial infarction MI 63 HOMA IR 63 vascular dysfunction 63 hepatic enzymes 63 untreated celiac disease 63 lichen planus 63 glycosylated hemoglobin levels 63 hyperphosphatemia 63 primidone 63 CLA supplementation 63 neurologic symptoms 63 interleukin IL -6 63 debilitating complication 63 serum phosphate levels 63 glycated hemoglobin 63 malabsorption 63 opioid analgesia 63 Daytime sleepiness 63 intracranial hypertension 62 glucagon secretion 62 hyperammonemia 62 thrombotic complications 62 hypertensives 62 nocturnal hypoglycemia 62 tolvaptan 62 arterial stiffening 62 perioperative complications 62 NAFLD 62 ATACAND 62 sensory neuropathy 62 systolic dysfunction 62 reinfarction 62 polyp recurrence 62 p# activation 62 liver histology 62 thromboembolic disease 62 Hashimoto thyroiditis 62 underlying pathophysiology 62 malperfusion 62 thrombocytopenic 62 albumin excretion rate 62 myocardial fibrosis 62 plasma lipid 62 ictal 62 chronic hepatitis cirrhosis 62 atherothrombotic 62 parasitemia 62 preserved ejection fraction 62 pericardial effusion 62 AA Amyloidosis 62 atrioventricular block 62 nonfasting triglyceride levels 62 urinary oxalate 62 syndrome OSAS 62 impaired fasting glucose 62 Critical limb ischemia 62 β2 62 hypothalamic pituitary adrenal axis 62 SSc 62 salmeterol HFA MDI 62 hematological parameters 62 posttransplant 62 lactic acidosis 62 untreated OSA 62 ventricular remodeling 62 fasting plasma glucose 62 apo B 62 neuroleptic malignant syndrome 62 HPA axis 62 fibrin deposition 62 virological response 62 nonfatal MI 62 TMP SMX 62 serum IGF 62 diabetes mellitus hypertension 62 hypoglycaemic episodes 62 serum calcium 62 platelet deficiency 62 uric acid levels 62 euthymic patients 62 neutropenia dehydration dyspnea 62 contrast induced nephropathy 62 hypersomnia 62 hypoglycemia unawareness 62 anemia thrombocytopenia 62 dose dependently 62 decompensation 62 cirrhotic patients 62 arterial stiffness 62 disease NAFLD 62 AAT deficiency 62 Diabetes mellitus 62 AST ALT 62 hemoglobin A1c levels 62 progressive neurodegenerative disorder 62 hyperresponsiveness 62 renal artery stenosis 62 coronary revascularization procedures 62 lymphopenia 62 autoimmune reactions 62 nondiabetic subjects 62 serum parathyroid hormone 62 Lupus nephritis 62 Ribavirin causes 62 Sleep disordered breathing 62 transfusion syndrome 62 serum sodium levels 62 myocardial ischaemia 62 cerebrovascular accident 62 isolated systolic hypertension 62 polyarticular 62 lung edema 62 Cognitive impairment 62 IDDM 62 SIADH 62 delayed gastric emptying 62 endothelial function 62 alkalosis 62 plasminogen activators 62 embolic stroke 62 hepatic toxicity 62 transferrin saturation 62 Chronic insomnia 62 frequent awakenings 62 neutropenia thrombocytopenia 62 hematologic toxicity 62 overt hypothyroidism 62 NIASPAN 62 basal cell nevus syndrome 62 Genetic predisposition 62 serum homocysteine 62 anterior uveitis 62 demyelinating disorders 62 aneurysmal subarachnoid hemorrhage 62 proinflammatory cytokines 62 gestational hypertension 62 fibrinolysis 62 HbF 62 selective modulator 62 extrapyramidal symptoms EPS 62 Albuminuria 62 lowers triglycerides 62 amenorrhoea 62 intracranial atherosclerosis 62 VAPRISOL 62 Gestational diabetes 62 fibrotic disease 62 comorbid conditions 62 GH deficiency 62 MADRS score 62 PTH secretion 62 baseline HbA1c 62 lightheadedness dizziness 62 cardioembolic stroke 62 urate levels 62 antidiabetic therapy 62 hematological toxicity 62 Infusion Reactions Severe 62 elevated cortisol 62 salivary cortisol 62 coagulation abnormalities 62 gestational diabetes mellitus GDM 62 Ketosis 62 serum lipids 62 parkinsonian 62 noncardiovascular mortality 62 tranylcypromine 62 T2D 62 dopamine antagonists 62 cardiac troponin 62 delayed CINV 62 gastro esophageal reflux 62 Hypercholesterolemia 62 QT intervals 62 antihypertensive therapy 62 oxygen desaturation 62 fetuin 62 Ischemic 62 motor neuron degeneration 62 MetS 62 HBeAg negative 62 neovascular 62 HF hospitalization 62 hepatotoxicity 62 HbA1C levels 62 thyrotropin levels 62 serum BDNF 62 Haptoglobin 62 autoregulation 62 #.#mmol L [002] 62 HER2 expression 62 cardiac tamponade 62 alexithymia 62 vasodilators 61 HER2 overexpression 61 rate variability HRV 61 VIIBRYD 61 plasma creatinine 61 peptide BNP 61 PTLD 61 cytomegalovirus infection 61 stable angina 61 triglyceride levels 61 postoperative morbidity 61 haemodynamic 61 CK MB 61 acute myocardial infarction AMI 61 fasting insulin 61 gastrointestinal disturbances 61 hypokalemia 61 interstitial pneumonia 61 lowers blood glucose 61 neurological abnormalities 61 antithrombotics 61 sinus tachycardia 61 salmeterol fluticasone 61 hepatic failure 61 neurodevelopmental impairment 61 cytopenia 61 systemic amyloidosis 61 induced ischemia 61 thyroid dysfunction 61 neurodevelopmental outcome 61 plasma homocysteine levels 61 catheter angiography 61 homozygous familial hypercholesterolemia 61 neurological complications 61 fasting plasma 61 serum urate 61 density lipoprotein HDL cholesterol 61 microvascular dysfunction 61 complement inhibitor eculizumab 61 insulin deficiency 61 LDL cholesterol concentrations 61 C1 INH deficiency 61 abnormal lipid 61 Tasigna prolongs 61 TNFalpha 61 coadministration 61 carotid IMT 61 anticholinergic agents 61 nitrotyrosine 61 beta blocker therapy 61 chorioamnionitis 61 IFN beta 61 carotid stenosis 61 diabetic nephropathy 61 hyperinsulinism 61 nonalcoholic fatty liver 61 vasospasm 61 OSAHS 61 glycated hemoglobin HbA1c 61 pulmonary hypertension PH 61 antidiabetic drugs 61 Hepatotoxicity 61 orthostatic hypotension 61 thyroid deficiency 61 chronic metabolic acidosis 61 coronary stenosis 61 renal allograft 61 neutropaenia 61 Prehypertension 61 idiopathic thrombocytopenic purpura 61 laboratory abnormalities 61 E selectin 61 Parkinsonian symptoms 61 intracerebral hemorrhage 61 adrenal function 61 nonadherence 61 persistent pulmonary hypertension 61 familial AF 61 hepatic glucose production 61 STRIDE PD 61 interleukin IL -# 61 Thyroid hormone 61 ischemic cardiomyopathy 61 neurological manifestations 61 muscarinic receptors 61 Peripheral neuropathy 61 diastolic function 61 pathophysiologic 61 pressure natriuresis 61 cardiac biomarkers 61 gouty arthritis 61 remnant lipoproteins 61 atopic disease 61 metabolic dysfunction 61 recurrent ischemia 61 Parkinson Disease PD 61 Generalized anxiety disorder 61 obstructive CAD 61 gastric adenocarcinoma 61 hippocampal atrophy 61 glycogen metabolism 61 EDARBI 61 Tardive dyskinesia 61 postprandial glycemia 61 SCr 61 inotropic 61 antiarrhythmic drugs 61 gastric carcinoma 61 adrenal exhaustion 61 failure NYHA 61 organ dysfunction 61 urticaria hives 61 cystatin C 61 synovial cells 61 arteries atherosclerosis 61 syncope 61 unfavorable cytogenetics 61 pulmonary arterial 61 insulin resistance precursor 61 lactate dehydrogenase LDH 61 CIMZIA ™ 61 obstructive sleep 61 vWD 61 comorbid disorders 61 plasminogen activator inhibitor 61 hemolytic 61 cardiolipin 61 hyperuricemia 61 Ivabradine 61 IGFBP 3 61 infarctions 61 pulmonary dysfunction 61 ventricular arrhythmia 61 albumin excretion 61 plasma cortisol 61 Exacerbations 61 vesicoureteral reflux 61 Ischaemic heart 61 inflammatory biomarkers 61 intermittent hypoxia 61 cAMP signaling 61 arterial calcification 61 Hemorrhagic stroke 61 bacteriuria 61 Thrombocytopenia 61 thrombo embolic 61 elevated CRP 61 autosomal dominant disorder 61 Chronic ITP 61 Estrogen deficiency 61 myalgias 61 PlGF 61 hyperoxaluria 61 granulomatous 61 bacterial prostatitis 61 BMPR2 61 adrenal insufficiency 61 Insulin sensitivity 61 Hb A1C 61 cardioprotection 61 distensibility 61 apolipoprotein B 61 antitumor efficacy 61 hypervolemic hyponatremia 61 nonvertebral fracture 61 HbA 1c 61 airway constriction 61 potassium deficiency 61 Insulin detemir 61 neuroleptics 61 co morbidities 61 plasma homocysteine 61 QTc interval 61 lipid parameters 61 antiangiogenic therapy 61 diabetic ketoacidosis DKA 61 pathophysiologic mechanisms 61 hypertensive rats 61 triglycerides 61 antidiabetic medication 61 Acute pancreatitis 61 claudication 61 diabetic complications 61 arterial thromboembolic events 61 Mitral regurgitation 61 cardiovascular mortality 61 cinacalcet 61 lipid lowering agents 61 Prediabetes 61 ischaemia 61 D dimer 61 adrenal suppression 61 cholinergic tone 61 GRNCM1 61 nephritis 61 amyloid β 61 systemic hypotension 61 lung fibrosis 61 TNF antagonist 61 left ventricular systolic 61 QT interval prolongation 61 atherogenic 61 diabetic gastroparesis 61 dermopathy 61 iron overload 61 vWF 61 pharmacologic intervention 61 Mild hypothermia 61 Hypertriglyceridemia 61 SGOT 61 atherogenesis 61 glomerular filtration rate 61 leptin receptor 61 COPD exacerbations 61 dysregulation 61 5 HTTLPR 61 Brugada syndrome 61 microglial activation 61 plasma glucose levels 61 NATRECOR ® 61 troponin T 61 hepatic liver 61 Chronic constipation 61 pro inflammatory cytokine 61 APTIVUS r 61 mechanically ventilated patients 61 GLP 1R 61 metformin Glucophage 61 Primary Hypercholesterolemia 61 hereditary predisposition 61 subsyndromal 61 left ventricular hypertrophy 61 glycemic variability 61 neurotrophic 61 candidemia 61 myeloproliferative neoplasms 61 serum estradiol 61 Low density lipoprotein 61 vitamin B1 deficiency 61 demyelinating 61 UA NSTEMI 61 blood lipids 61 catecholamine 61 metastatic carcinoid tumors 61 repolarization 60 neurocognitive outcomes 60 cerebral oxygenation 60 reperfusion injury 60 Neuroleptic Malignant Syndrome NMS 60 triiodothyronine 60 enzyme elevations 60 serum lipid levels 60 malarial anemia 60 recurrent wheezing 60 chronic pancreatitis CP 60 antiplatelet drugs 60 pheochromocytoma 60 triacylglycerol 60 apolipoprotein E4 60 PLX STROKE targeting 60 neurohormonal activation 60 leptin deficiency 60 hematopoietic cancers 60 hsCRP levels 60 liver metastasis 60 angiographically 60 Folate deficiency 60 hemolytic anemia 60 parkinsonism 60 elevated lipase 60 coronary stenoses 60 COPD exacerbation 60 cystoid macular edema 60 VLDL cholesterol 60 hyperlipemia 60 echocardiographic parameters 60 allergic inflammation 60 Pseudomonas aeruginosa infections 60 uncontrolled asthma 60 HMG CoA reductase inhibitors 60 carbohydrate intolerance 60 de ath 60 olmesartan 60 PSADT 60 isoenzyme 60 vascular reactivity 60 monocyte chemoattractant protein 60 Severe Primary IGFD 60 intravenous cyclophosphamide 60 potassium sparing diuretics 60 hyperglycaemic 60 ventricular fibrillation VF 60 macrovascular 60 cerebral perfusion 60 glucose tolerance 60 Critical Limb Ischemia CLI 60 tryptase 60 aspartate aminotransferase 60 interferon γ 60 cryptogenic 60 total cholesterol triglycerides 60 allograft rejection 60 colic diarrhea 60 aminotransferase ALT 60 aldosterone hormone 60 myocardial infarction 60 coronary artery atherosclerosis 60 elevated IOP 60 steatohepatitis 60 acute aortic dissection 60 HDL LDL ratio 60 retransplantation 60 Cystatin C 60 cardioprotective effect 60 chronic myocardial ischemia 60 vasodilatory 60 premenstrual syndrome PMS 60 HDL Cholesterol 60 dyslipidemias 60 status epilepticus 60 DVT PE 60 acid suppressive therapy 60 pouchitis 60 oxidized cysteine 60 endometrial hyperplasia 60 Hurthle cell 60 lipid disorders 60 cerebral infarctions 60 vasoconstriction 60 morbidity mortality 60 Postoperative 60 oral anticoagulation 60 infarcts 60 demyelination 60 receiving XGEVA 60 hypercholesterolemic patients 60 multisystem disease 60 bacteraemia 60 Torsades de Pointes 60 amino acid metabolism 60 incretin hormones 60 sFlt 1 60 canakinumab 60 metabolic derangements 60 refractory ischemia 60 triglyceride concentration 60 LVSD 60 liver scarring 60 prostate cancer CaP 60 Oral mucositis 60 kainate 60 serum aminotransferase levels 60 renovascular hypertension 60 urinary albumin excretion 60 IGFBP 60 plasma glucose 60 CETP inhibition 60 herpes simplex encephalitis 60 AVAPRO 60 paroxysmal supraventricular tachycardia 60 coronary artery disease 60 proteinuria 60 vitreous floaters 60 haemorrhagic strokes 60 Fatty liver 60 gastrointestinal perforation 60 adrenocorticotropic hormone 60 Generalized Anxiety Disorder 60 anticoagulant warfarin 60 induced cardiomyopathy 60 lymphoproliferative disorder 60 MMSE scores 60 IL 1ß 60 Triglyceride levels 60 fulminant hepatitis 60 TCF#L# 60 elevated LDL 60 impaired hepatic 60 Nonalcoholic Fatty Liver Disease 60 Genetic variants 60 H. pylori eradication 60 ventricular dysfunction 60 orthostatic 60 potentially modifiable 60 pioglitazone HCl 60 juvenile idiopathic arthritis JIA 60 pancreatitis inflammation 60 metabolic abnormality 60 AGILECT R 60 PLMs 60 NQO1 60 virologic breakthrough 60 neurologic disorder 60 temporal arteritis 60 ALB # 60 neurodevelopmental disability 60 affective psychoses 60 metformin sulfonylurea 60 functional dyspepsia 60 Cholinesterase inhibitors 60 angina pectoris 60 antiemetics 60 normotensive 60 serum retinol 60 purpura ITP 60 atherosclerosis 60 biochemical abnormalities 60 alcoholic fatty liver 60 cirrhotic liver 60 Clusterin 60 idiopathic Parkinson disease 60 esophageal reflux 60 EBV infection 60 recurrent UTI 60 vasogenic edema

Back to home page